{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T04:09:55Z","timestamp":1791173395647,"version":"4.1.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,10,21]],"date-time":"2013-10-21T00:00:00Z","timestamp":1382313600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1186\/1471-2407-13-490","type":"journal-article","created":{"date-parts":[[2013,10,21]],"date-time":"2013-10-21T20:08:25Z","timestamp":1382386105000},"source":"Crossref","is-referenced-by-count":23,"title":["Salinomycin increases chemosensitivity to the effects of doxorubicin in soft tissue sarcomas"],"prefix":"10.1186","volume":"13","author":[{"given":"Sven-T","family":"Liffers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel J","family":"Tilkorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingo","family":"Stricker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph G\u00fcnter","family":"Junge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sammy","family":"Al-Benna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Vogt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Berlinda","family":"Verdoodt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans-U","family":"Steinau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Tannapfel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iris","family":"Tischoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alireza","family":"Mirmohammadsadegh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,10,21]]},"reference":[{"key":"4114_CR1","volume-title":"World Health Organisation classification of tumours pathology and genetics of tumours of soft tissue and bone","author":"SM Fletcher CDM","year":"2002","unstructured":"Fletcher CDM SM, Rydholm A, Coindre JM, Singer S: Soft tissue tumours: Epidemiology, clinical features, histopathological typing and grading. World Health Organisation classification of tumours pathology and genetics of tumours of soft tissue and bone. Edited by: Christopher DM, Fletcher K, Unni K, Mertens F. 2002, Lyon: World Health Organization"},{"key":"4114_CR2","doi-asserted-by":"publisher","first-page":"200","DOI":"10.3322\/canjclin.44.4.200","volume":"44","author":"CP Karakousis","year":"1994","unstructured":"Karakousis CP, Perez RP: Soft tissue sarcomas in adults. CA Cancer J Clin. 1994, 44: 200-210. 10.3322\/canjclin.44.4.200.","journal-title":"CA Cancer J Clin"},{"key":"4114_CR3","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.critrevonc.2006.11.008","volume":"62","author":"B Kasper","year":"2007","unstructured":"Kasper B, Gil T, D\u2019Hondt V, Gebhart M, Awada A: Novel treatment strategies for soft tissue sarcoma. Crit Rev Oncol Hematol. 2007, 62: 9-15. 10.1016\/j.critrevonc.2006.11.008.","journal-title":"Crit Rev Oncol Hematol"},{"key":"4114_CR4","first-page":"80","volume-title":"American cancer society atlas of clinical oncology: soft tissue sarcomas","author":"P Pisters","year":"2002","unstructured":"Pisters P: Staging and prognosis. American cancer society atlas of clinical oncology: soft tissue sarcomas. Edited by: Pollock RE. 2002, Hamilton, Ontario: BC Decker, Inc, 80-88."},{"key":"4114_CR5","first-page":"1512","volume":"3","author":"JL Nitiss","year":"2002","unstructured":"Nitiss JL: DNA topoisomerases in cancer chemotherapy: using enzymes to generate selective DNA damage. Curr Opin Investig Drugs. 2002, 3: 1512-1516.","journal-title":"Curr Opin Investig Drugs"},{"key":"4114_CR6","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.bcp.2005.10.041","volume":"71","author":"GL Bidwell 3rd","year":"2006","unstructured":"Bidwell GL, Raucher D: Enhancing the antiproliferative effect of topoisomerase II inhibitors using a polypeptide inhibitor of c-Myc. Biochem Pharmacol. 2006, 71: 248-256. 10.1016\/j.bcp.2005.10.041.","journal-title":"Biochem Pharmacol"},{"key":"4114_CR7","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/j.bcp.2007.10.012","volume":"75","author":"CJ Hsiao","year":"2008","unstructured":"Hsiao CJ, Li TK, Chan YL, Hsin LW, Liao CH, Lee CH, Lyu PC, Guh JH: WRC-213, an l-methionine-conjugated mitoxantrone derivative, displays anticancer activity with reduced cardiotoxicity and drug resistance: identification of topoisomerase II inhibition and apoptotic machinery in prostate cancers. Biochem Pharmacol. 2008, 75: 847-856. 10.1016\/j.bcp.2007.10.012.","journal-title":"Biochem Pharmacol"},{"key":"4114_CR8","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1634\/theoncologist.10-10-780","volume":"10","author":"S Gluck","year":"2005","unstructured":"Gluck S: Adjuvant chemotherapy for early breast cancer: optimal use of epirubicin. Oncologist. 2005, 10: 780-791. 10.1634\/theoncologist.10-10-780.","journal-title":"Oncologist"},{"issue":"Suppl 1","key":"4114_CR9","first-page":"S12","volume":"3","author":"S Gluck","year":"2005","unstructured":"Gluck S: New advances in the management of metastatic breast cancer. J Natl Compr Canc Netw. 2005, 3 (Suppl 1): S12-S16.","journal-title":"J Natl Compr Canc Netw"},{"key":"4114_CR10","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1093\/annonc\/mdl417","volume":"18","author":"CE Humber","year":"2007","unstructured":"Humber CE, Tierney JF, Symonds RP, Collingwood M, Kirwan J, Williams C, Green JA: Chemotherapy for advanced, recurrent or metastatic endometrial cancer: a systematic review of cochrane collaboration. Ann Oncol. 2007, 18: 409-420.","journal-title":"Ann Oncol"},{"key":"4114_CR11","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1080\/03008200802147829","volume":"49","author":"H Thomadaki","year":"2008","unstructured":"Thomadaki H, Scorilas A: Molecular profile of the BCL2 family of the apoptosis related genes in breast cancer cells after treatment with cytotoxic\/cytostatic drugs. Connect Tissue Res. 2008, 49: 261-264. 10.1080\/03008200802147829.","journal-title":"Connect Tissue Res"},{"key":"4114_CR12","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1007\/s00280-009-0950-8","volume":"64","author":"P Chakraborty","year":"2009","unstructured":"Chakraborty P, Sk UH, Bhattacharya S: Chemoprotection and enhancement of cancer chemotherapeutic efficacy of cyclophosphamide in mice bearing Ehrlich ascites carcinoma by diphenylmethyl selenocyanate. Cancer Chemother Pharmacol. 2009, 64: 971-980. 10.1007\/s00280-009-0950-8.","journal-title":"Cancer Chemother Pharmacol"},{"key":"4114_CR13","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/j.cell.2009.06.034","volume":"138","author":"PB Gupta","year":"2009","unstructured":"Gupta PB, Onder TT, Jiang G, Tao K, Kuperwasser C, Weinberg RA, Lander ES: Identification of selective inhibitors of cancer stem cells by high-throughput screening. Cell. 2009, 138: 645-659. 10.1016\/j.cell.2009.06.034.","journal-title":"Cell"},{"key":"4114_CR14","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1016\/j.bbrc.2009.10.042","volume":"390","author":"D Fuchs","year":"2009","unstructured":"Fuchs D, Heinold A, Opelz G, Daniel V, Naujokat C: Salinomycin induces apoptosis and overcomes apoptosis resistance in human cancer cells. Biochem Biophys Res Commun. 2009, 390: 743-749. 10.1016\/j.bbrc.2009.10.042.","journal-title":"Biochem Biophys Res Commun"},{"key":"4114_CR15","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1111\/j.1476-5381.2010.01089.x","volume":"162","author":"JH Kim","year":"2011","unstructured":"Kim JH, Chae M, Kim WK, Kim YJ, Kang HS, Kim HS, Yoon S: Salinomycin sensitizes cancer cells to the effects of doxorubicin and etoposide treatment by increasing DNA damage and reducing p21 protein. Br J Pharmacol. 2011, 162: 773-784. 10.1111\/j.1476-5381.2010.01089.x.","journal-title":"Br J Pharmacol"},{"key":"4114_CR16","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1007\/s10637-011-9685-6","volume":"30","author":"WK Kim","year":"2011","unstructured":"Kim WK, Kim JH, Yoon K, Kim S, Ro J, Kang HS, Yoon S: Salinomycin, a p-glycoprotein inhibitor, sensitizes radiation-treated cancer cells by increasing DNA damage and inducing G2 arrest. Invest New Drugs. 2011, 30: 1311-1318.","journal-title":"Invest New Drugs"},{"key":"4114_CR17","volume-title":"Toxicity and Drug Testing","author":"H-G Breitinger","year":"2012","unstructured":"Breitinger H-G: Drug synergy \u2013 mechanisms and methods of analysis. Toxicity and Drug Testing. Edited by: Acree W. 2012, http:\/\/www.intechopen.com\/books\/toxicity-and-drug-testing\/drug-synergy-mechanisms-and-methods-of-analysis ,"},{"key":"4114_CR18","doi-asserted-by":"publisher","first-page":"e6992","DOI":"10.1371\/journal.pone.0006992","volume":"4","author":"BK Bednarski","year":"2009","unstructured":"Bednarski BK, Baldwin AS, Kim HJ: Addressing reported pro-apoptotic functions of NF-kappaB: targeted inhibition of canonical NF-kappaB enhances the apoptotic effects of doxorubicin. PLoS One. 2009, 4: e6992-10.1371\/journal.pone.0006992.","journal-title":"PLoS One"},{"key":"4114_CR19","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1038\/sj.onc.1201638","volume":"16","author":"AC Hellin","year":"1998","unstructured":"Hellin AC, Calmant P, Gielen J, Bours V, Merville MP: Nuclear factor - kappaB-dependent regulation of p53 gene expression induced by daunomycin genotoxic drug. Oncogene. 1998, 16: 1187-1195. 10.1038\/sj.onc.1201638.","journal-title":"Oncogene"},{"key":"4114_CR20","doi-asserted-by":"publisher","first-page":"35240","DOI":"10.1074\/jbc.274.49.35240","volume":"274","author":"XH Pei","year":"1999","unstructured":"Pei XH, Nakanishi Y, Takayama K, Bai F, Hara N: Benzo[a]pyrene activates the human p53 gene through induction of nuclear factor kappaB activity. J Biol Chem. 1999, 274: 35240-35246. 10.1074\/jbc.274.49.35240.","journal-title":"J Biol Chem"},{"key":"4114_CR21","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1038\/nrc1232","volume":"3","author":"R Pardal","year":"2003","unstructured":"Pardal R, Clarke MF, Morrison SJ: Applying the principles of stem-cell biology to cancer. Nat Rev Cancer. 2003, 3: 895-902. 10.1038\/nrc1232.","journal-title":"Nat Rev Cancer"},{"key":"4114_CR22","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1016\/j.bbrc.2010.03.138","volume":"394","author":"D Fuchs","year":"2010","unstructured":"Fuchs D, Daniel V, Sadeghi M, Opelz G, Naujokat C: Salinomycin overcomes ABC transporter-mediated multidrug and apoptosis resistance in human leukemia stem cell-like KG-1a cells. Biochem Biophys Res Commun. 2010, 394: 1098-1104. 10.1016\/j.bbrc.2010.03.138.","journal-title":"Biochem Biophys Res Commun"},{"key":"4114_CR23","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1245\/s10434-011-1561-2","volume":"18","author":"TT Dong","year":"2011","unstructured":"Dong TT, Zhou HM, Wang LL, Feng B, Lv B, Zheng MH: Salinomycin selectively targets 'CD133\u2009+\u2019 cell subpopulations and decreases malignant traits in colorectal cancer lines. Ann Surg Oncol. 2011, 18: 1797-1804. 10.1245\/s10434-011-1561-2.","journal-title":"Ann Surg Oncol"},{"key":"4114_CR24","doi-asserted-by":"publisher","first-page":"e44132","DOI":"10.1371\/journal.pone.0044132","volume":"7","author":"B Verdoodt","year":"2012","unstructured":"Verdoodt B, Vogt M, Schmitz I, Liffers ST, Tannapfel A, Mirmohammadsadegh A: Salinomycin induces autophagy in colon and breast cancer cells with concomitant generation of reactive oxygen species. PLoS One. 2012, 7: e44132-10.1371\/journal.pone.0044132.","journal-title":"PLoS One"},{"key":"4114_CR25","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1038\/35009130","volume":"404","author":"KM Ryan","year":"2000","unstructured":"Ryan KM, Ernst MK, Rice NR, Vousden KH: Role of NF-kappaB in p53-mediated programmed cell death. Nature. 2000, 404: 892-897. 10.1038\/35009130.","journal-title":"Nature"},{"key":"4114_CR26","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1038\/sj.onc.1203246","volume":"19","author":"D Javelaud","year":"2000","unstructured":"Javelaud D, Wietzerbin J, Delattre O, Besancon F: Induction of p21Waf1\/Cip1 by TNFalpha requires NF-kappaB activity and antagonizes apoptosis in ewing tumor cells. Oncogene. 2000, 19: 61-68. 10.1038\/sj.onc.1203246.","journal-title":"Oncogene"},{"key":"4114_CR27","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.abb.2009.07.017","volume":"489","author":"Y Zhang","year":"2009","unstructured":"Zhang Y, Wu Y, Wu D, Tashiro S, Onodera S, Ikejima T: NF-kappab facilitates oridonin-induced apoptosis and autophagy in HT1080 cells through a p53-mediated pathway. Arch Biochem Biophys. 2009, 489: 25-33. 10.1016\/j.abb.2009.07.017.","journal-title":"Arch Biochem Biophys"},{"key":"4114_CR28","doi-asserted-by":"publisher","first-page":"43534","DOI":"10.1074\/jbc.M104257200","volume":"276","author":"LH Zhang","year":"2001","unstructured":"Zhang LH, Youn HD, Liu JO: Inhibition of cell cycle progression by the novel cyclophilin ligand sanglifehrin A is mediated through the NFkappa B-dependent activation of p53. J Biol Chem. 2001, 276: 43534-43540. 10.1074\/jbc.M104257200.","journal-title":"J Biol Chem"},{"key":"4114_CR29","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1038\/cdd.2009.51","volume":"16","author":"P Wang","year":"2009","unstructured":"Wang P, Qiu W, Dudgeon C, Liu H, Huang C, Zambetti GP, Yu J, Zhang L: PUMA is directly activated by NF-kappaB and contributes to TNF-alpha-induced apoptosis. Cell Death Differ. 2009, 16: 1192-1202. 10.1038\/cdd.2009.51.","journal-title":"Cell Death Differ"},{"key":"4114_CR30","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1038\/ncb2100","volume":"12","author":"D Liu","year":"2010","unstructured":"Liu D, Ou L, Clemenson GD, Chao C, Lutske ME, Zambetti GP, Gage FH, Xu Y: Puma is required for p53-induced depletion of adult stem cells. Nat Cell Biol. 2010, 12: 993-998. 10.1038\/ncb2100.","journal-title":"Nat Cell Biol"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-13-490.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2407-13-490\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-13-490","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2016,7,12]],"date-time":"2016-07-12T19:49:48Z","timestamp":1468352988000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/1471-2407-13-490"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10,21]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["4114"],"URL":"https:\/\/doi.org\/10.1186\/1471-2407-13-490","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,10,21]]},"article-number":"490"}}